A diglyceride derivative of a pentapeptide renin inhibitor, the almito
yl-[Iva-Phe-Nle-Sta-Ala-Sta-acetyl]-glycerol was synthesized and teste
d in vitro as a potential prodrug for oral administration. The ability
of the diglyceride analog to inhibit the renin activity was equivalen
t to that of the parent peptide after predigestion with pancreatic lip
ase. Furthermore, the presence of the palmitoyl groups was found to in
duce, in vitro, an efficient protection of the peptide from gastric an
d intestinal hydrolysis. During incubation with intestinal and gastric
fluids, and with alpha-chymotrypsin and pancreatic lipase, the glycer
olipidic derivative was more stable than the peptide alone. These resu
lts support the use of glycerolipidic prodrug for oral administration
of peptides.